f8k111313_chinajojo.htm
 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 
 
 
Date of report (Date of earliest event reported):  November 13, 2013
 
CHINA JO-JO DRUGSTORES, INC.
(Exact name of registrant as specified in its charter)
 
Nevada
  
001-34711
  
98-0557852
(State or other jurisdiction of incorporation)
  
(Commission File No.)
  
(IRS EmployerIdentification No.)
 
Room 507-513, 5th Floor, A Building, Meidu Plaza
Gongshu District, Hangzhou, Zhejiang Province
People’s Republic of China
    
(Address of principal executive offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code +86 (571) 88077078
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
 
 
 
Item 8.01. Other Events.
 
On November 13, 2013, the registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1, and the information in Exhibit 99.1 is incorporated herein by reference.
 
The information in Item 8.01 and Item 9.01(d) in this Current Report on Form 8-K and the exhibit attached hereto shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as expressly set forth by specific reference in such a filing.
 
Item 9.01   Financial Statement and Exhibits.

(d)EXHIBITS

Exhibit Number
  
Description
99.1
  
Press release dated November 13, 2013
 
 
 
 
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

   
CHINA JO-JO DRUGSTORES, INC.
Date:
November 13, 2013
(Registrant)
       
   
By:
/s/ Ming Zhao
     
Ming Zhao
     
Chief Financial Officer